History
of capital
The table below provides
an overview of the history
of the company’s share
capital since its corporation
on May 30th 2006.
On October 21 2008 there was a number of 1.424.365 warrants/options still outstanding of which 874.000 warrants are issued by ThromboGenics NV and 550.365 options are related to the pre-IPO Irish approved and non-approved plans issued by ThromboGenics Ltd.
| Date |
Transaction |
Number of shares issued |
Issue price per share (€) |
Capital Increase (€) |
Issue Premium paid (€) |
Share capital
after transaction (€) |
Aggregate number of shares after transaction |
| May 30th 2006 |
Incorporation |
11.124 |
5,57 |
|
|
62.000,00 |
11.124 |
| July 5th 2006 |
Contribution
in
kind |
14.351.403 |
4.50 |
64.581.313,50 |
- |
64.643.313,50 |
14.362.527 |
| July 7th 2006 |
Capital increase
in
cash |
7.777.778 |
4.50 |
35.000.001,00 |
- |
99.643.314,50 |
22.140.305 |
| May 9th 2007 |
Capital increase in cash |
2.214.030 |
4.50 |
9.964.329,20 |
13.947.194,80 |
109.607.643,70 |
24.354.335 |
| Sept 13th 2007 |
Exercise of warrants |
1.147.825 |
4.50 |
5.165.212,50 |
1.699.937,50 |
114.772.856,20 |
25.502.160 |
| April 8th 2008 |
Exercise of warrants |
172.629 |
4,50 |
776.919,43 |
86.225,57 |
115.549.775,63 |
25.674.789 |
Oct 10th
2008 |
Exercise of warrants |
56.000 |
4,50 |
252.028,85 |
103.171,15 |
115.801.804,48 |
25.730.789 |
April 9th
2009 |
Exercise of warrants |
38.000 |
4,50 |
171.019,58 |
70.580,42 |
115.972.804,48 |
25.768.789 |
April 30th
2009 |
Exercise of warrants |
559.000 |
4,45 |
2.487.550,00 |
- |
118.460.374,06 |
26.327.789 |
Oct 5th
2009 |
Exercise of
warrants |
90.000 |
4,50 |
404.949,83 |
231.420,17 |
118.865.323,89 |
26.417.789 |
Nov 20st
2009 |
Capital increase in cash |
2.641.778 |
4,50 |
11.886.528,34 |
30.381.919,66 |
130.751.852,23 |
29.059.567 |
| March 22nd 2010 |
Exercise of warrants |
96.667 |
4,50 |
434.947,62 |
139.431,93 |
131.186.799,85 |
29.156.234 |
|
All rights reserved © Thrombogenic 2006